Ken Griffin Biotechnology

Citadel Advisors LLC

  • $509 Billion
  • Q1 2025

Stock List

Stock Option Type Value Options Held Last Trade Trade History
IMTX
Immatics N.V.
CALL
$640,000
142K
Q1 2025
Reduced 12.44%
PTCT
Ptc Therapeutics, Inc.
CALL
$626,000
12.3K
Q1 2025
Added 154.93%
QSI
Quantum Si Inc
PUT
$626,000
522K
Q1 2025
New holding
CRNX
Crinetics Pharmaceuticals, Inc.
CALL
$617,000
18.4K
Q1 2025
Added 716.41%
REPL
Replimune Group, Inc.
PUT
$610,000
62.6K
Q1 2025
Reduced 83.31%
CLDX
Celldex Therapeutics, Inc.
CALL
$609,000
33.6K
Q1 2025
Reduced 14.78%
VRDN
Viridian Therapeutics, Inc.\De
PUT
$607,000
45.1K
Q1 2025
Reduced 75.29%
LEGN
Legend Biotech Corp
PUT
$600,000
17.7K
Q1 2025
Reduced 94.66%
TECH
Bio Techne Corp
PUT
$580,000
9.9K
Q1 2025
Reduced 73.85%
ABSI
Absci Corp
PUT
$564,000
225K
Q1 2025
Added 146.38%
MNKD
Mannkind Corp
PUT
$562,000
112K
Q1 2025
Reduced 35.47%
VERA
Vera Therapeutics, Inc.
CALL
$552,000
23K
Q1 2025
Added 286.44%
SAVA
Cassava Sciences Inc
CALL
$547,000
365K
Q1 2025
New holding
DAWN
Day One Biopharmaceuticals, Inc.
PUT
$547,000
69K
Q1 2025
Added 119.04%
KRYS
Krystal Biotech, Inc.
PUT
$522,000
2.9K
Q1 2025
Reduced 99.13%
CPRX
Catalyst Pharmaceuticals, Inc.
CALL
$514,000
21.2K
Q1 2025
Added 57.04%
ARWR
Arrowhead Pharmaceuticals, Inc.
CALL
$507,000
39.8K
Q1 2025
Added 168.19%
WVE
Wave Life Sciences Ltd.
PUT
$506,000
62.7K
Q1 2025
Added 1825.3%
AMRN
Amarin Corp Plcuk
CALL
$499,000
55.7K
Q4 2024
Added 32.33%
IDYA
Ideaya Biosciences, Inc.
PUT
$499,000
30.5K
Q1 2025
Reduced 18.06%
IMTX
Immatics N.V.
PUT
$492,000
109K
Q1 2025
Reduced 12.44%
KALV
Kal Vista Pharmaceuticals, Inc.
CALL
$489,000
42.4K
Q4 2024
Added 7.26%
LGND
Ligand Pharmaceuticals Inc
PUT
$483,000
4.6K
Q3 2024
Reduced 48.02%
VRDN
Viridian Therapeutics, Inc.\De
CALL
$479,000
35.6K
Q1 2025
Reduced 75.29%
ARQT
Arcutis Biotherapeutics, Inc.
PUT
$478,000
30.6K
Q1 2025
Added 247.74%
GLPG
Galapagos Nv
CALL
$462,000
18.4K
Q4 2024
Reduced 14.84%
ITOS
I Teos Therapeutics, Inc.
PUT
$458,000
76.8K
Q1 2025
Reduced 17.63%
KMPH
Kempharm, Inc
CALL
$458,000
92.8K
Q1 2025
Added 9897.27%
ALDX
Aldeyra Therapeutics, Inc.
CALL
$457,000
79.5K
Q4 2024
Added 58.15%
MRUS
Merus N.V.
CALL
$454,000
10.8K
Q1 2025
Added 233.07%
RCKT
Rocket Pharmaceuticals, Inc.
PUT
$451,000
67.7K
Q1 2025
Reduced 63.4%
JANX
Janux Therapeutics, Inc.
PUT
$450,000
16.7K
Q1 2025
Reduced 48.07%
OCUL
Ocular Therapeutix, Inc
PUT
$450,000
61.5K
Q1 2025
Added 7.95%
RVPH
Reviva Pharmaceuticals Holdings, Inc.
CALL
$450,000
475K
Q1 2025
New holding
FOLD
Amicus Therapeutics, Inc.
PUT
$440,000
54K
Q1 2025
Reduced 4.86%
PTCT
Ptc Therapeutics, Inc.
PUT
$438,000
8.6K
Q1 2025
Added 154.93%
EYPT
Eye Point Pharmaceuticals, Inc.
CALL
$428,000
79.1K
Q1 2025
Reduced 7.33%
KURA
Kura Oncology, Inc.
PUT
$425,000
64.5K
Q1 2025
Reduced 60.05%
TECH
Bio Techne Corp
CALL
$422,000
7.2K
Q1 2025
Reduced 73.85%
AKRO
Akero Therapeutics, Inc.
CALL
$420,000
10.4K
Q1 2025
Added 40.92%
NVCT
Nuvectis Pharma, Inc.
CALL
$420,000
43K
Q1 2025
New holding
CMRX
Chimerix Inc
CALL
$419,000
49.3K
Q1 2025
Reduced 88.62%
MRUS
Merus N.V.
PUT
$408,000
9.7K
Q1 2025
Added 233.07%
TARS
Tarsus Pharmaceuticals, Inc.
PUT
$390,000
7.6K
Q1 2025
Added 1151.11%
CRNX
Crinetics Pharmaceuticals, Inc.
PUT
$389,000
11.6K
Q1 2025
Added 716.41%
BCRX
Biocryst Pharmaceuticals Inc
CALL
$382,000
51K
Q1 2025
Added 122.08%
GERN
Geron Corp
CALL
$378,000
238K
Q1 2025
Added 59.25%
MLTX
Moon Lake Immunotherapeutics
PUT
$378,000
9.7K
Q1 2025
Reduced 32.39%
ABCL
Ab Cellera Biologics Inc.
PUT
$377,000
169K
Q1 2025
Added 203.8%
Filter Shares Options
Ken Griffin

Ken Griffin

Ken Griffin is the founder and CEO of Citadel Advisors, a successful investment firm that uses technology and data-driven approaches to investing. Griffin is known for his expertise in quantitative investing and his innovative approach to investing. He has generated strong returns for his clients over the long term.
Track Ken Griffin's portfolio
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email